|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.16 EUR | -0.15% |
|
-0.82% | -22.20% |
| 07-02 | Cartesian Therapeutics, Inc. Appoints Kemal Malik to its Board of Directors | CI |
| 06-28 | Borse Frankfurt-News: Uncertainty ahead of French election (Bond Trading) | DP |
(Reuters) - Activist investor Bluebell Capital Partners has built a stake in Bayer AG and is pushing for a breakup of the German pharmaceutical and agriculture company, Bloomberg reported on Tuesday, citing sources.
UK-based Bluebell is also seeking an overhaul of Bayer's corporate governance, the report added.
A Bayer spokesperson, who declined to comment on the report, said: "Generally speaking we are always open for a constructive dialogue with our stakeholders."
(Reporting by Shivani Tanna in Bengaluru. Additional reporting by Tom Sims in Frankfurt. Editing by Jane Merriman)
| 1st Jan change | Capi. | |
|---|---|---|
| -22.20% | 27.83B | |
| +56.89% | 809B | |
| +39.52% | 624B | |
| -6.55% | 351B | |
| +7.92% | 289B | |
| +13.74% | 240B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 166B | |
| -2.57% | 157B |
BAYER AG 
